AR and neoplasm: In 5–10% of CRPC cases, AR gene rearrangements exist as the only AR alteration detectable, and in this context they promote synthesis of tumor-unique AR variants (AR-V) that lack the AR ligand binding domain and possess constitutive activity that supports growth of CRPC cells (9,13,15).